Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment

被引:8
|
作者
Pinotti, Caitlan S. [1 ]
Cannon, Laura [2 ]
Dvergsten, Jeffrey A. [1 ]
Wu, Eveline Y. [2 ,3 ]
机构
[1] Duke Univ, Dept Pediat, Div Pediat Rheumatol, Durham, NC 27708 USA
[2] Univ N Carolina, Dept Pediat, Div Pediat Rheumatol, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Dept Pediat, Div Pediat Allergy & Immunol, Chapel Hill, NC USA
关键词
juvenile dermatomyositis; calcinosis; myositis-specific antibody; pathogenesis; treatment; INFLAMMATORY MYOPATHIES; MYOSITIS; DISEASE; AUTOANTIBODIES; RECALCITRANT; FEATURES; CHILDREN;
D O I
10.3389/fmed.2023.1155839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcinosis, or the deposition of insoluble calcium salts in the skin, subcutaneous tissue, fascia, tendons, and muscles, is a feared complication of juvenile dermatomyositis. Calcinosis is estimated to affect up to 40% of patients with juvenile dermatomyositis and contributes to significant disease morbidity. Calcinosis can be challenging to treat, and the most effective treatment remains unknown because of a lack of comparative studies. We aim to review the literature published in the last 5 years to summarize updates on the pathogenesis and treatment of calcinosis in juvenile dermatomyositis and describe future areas for research.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin
    Yang, Ming-Chun
    Lee, Jyh-Hong
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2008, 11 (01) : 77 - 80
  • [42] Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging
    Yi, Belina Y.
    Marrs, Joshua
    Acharya, Patricia
    Sura, Amit
    Cidon, Michal
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (11) : 2577 - 2582
  • [43] Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis
    Bedangshu Saikia
    Himanshu Aneja
    Jyoti Jain
    Jacob M. Puliyel
    Clinical Rheumatology, 2013, 32 : 51 - 53
  • [44] Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis
    Saikia, Bedangshu
    Aneja, Himanshu
    Jain, Jyoti
    Puliyel, Jacob M.
    CLINICAL RHEUMATOLOGY, 2013, 32 : S51 - S53
  • [45] Juvenile dermatomyositis: extramuscular manifestations and their management
    Lowry, Clodagh A.
    Pilkington, Clarissa A.
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (06) : 575 - 580
  • [46] Juvenile dermatomyositis: A series of 22 cases
    Moegle, C.
    Lipsker, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (8-9): : 494 - 503
  • [47] Juvenile dermatomyositis: a tertiary center experience
    Barut, Kenan
    Aydin, Pinar Ozge Avar
    Adrovic, Amra
    Sahin, Sezgin
    Kasapcopur, Ozgur
    CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 361 - 366
  • [48] Juvenile dermatomyositis complicated by calcinosis universalis: Importance of early disease recognition
    Abdwani, Reem
    Al-Futaisi, Amna
    Jain, Rajeev
    Koul, Roshan
    JOURNAL OF PEDIATRIC NEUROLOGY, 2008, 6 (04) : 371 - 374
  • [49] Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
    Takako Miyamae
    Fumie Sano
    Remi Ozawa
    Tomoyuki Imagawa
    Yoshiaki Inayama
    Shumpei Yokota
    Pediatric Rheumatology, 8
  • [50] Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
    A. B. Orandi
    K. W. Baszis
    V. R. Dharnidharka
    A. M. Huber
    M. F. Hoeltzel
    Pediatric Rheumatology, 15